Outlining the sector’s wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments
Budget 2024: Pharma industry seeks tax benefits, effective intellectual property rights regime
